Aimei Health Technology AFJK
- Market cap
- $38.6M
- Revenue, 12 months
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| −$153.6K | −$309.1K | −$200K | −$402K | −$413.4K+169% | −$41.6K−87% | −$130.2K−35% | −$250.6K−38% | −$62K−85% | −$192.3K+362% | |
| Net income | $755.5K | $609.1K | $743.5K | $444.1K | $184.7K−76% | $425K−30% | $352K−53% | $98.1K−78% | $45.4K−75% | −$83.1K |
| $0.08 | $0.07 | $0.08 | $0.21 | $0.03−63% | $0.07+0% | $0.06−25% | $0.05−76% | $0.01−67% | −$0.03 | |
| 2.1M | 2.1M | 2.1M | 2.1M | 2.1M+0% | 2.1M+0% | 2.1M+0% | 2.1M+0% | 2.1M+0% | 2.1M+0% |
EPS, diluted: Q4 FY24 and Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Aimei Health Technology's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AFJKAimei Health Technology | $38.6M | n/m | 92.2× | n/m | n/m | n/m | |
| MBBCMarathon Bancorp | $44.1M | 21.9× | 32.4× | n/m | +33% | 19.8% | |
| GROWU S Global Investors | $33M | 11.2× | 18.7× | 3.2× | +21% | 29.8% | |
| TCBSTexas Community Bancshares | $49.6M | 14.3× | 22.6× | n/m | +14% | 19.1% | |
| RSSSResearch Solutions | $62.6M | 20.6× | 22.2× | 1.3× | −2% | 5.8% | |
| CLSTCatalyst Bancorp | $71.7M | 32.9× | 30.6× | n/m | −2% | 18.0% | |
| ATCHAtlasClear | $20.6M | 13.6× | 16.7× | 1.0× | +85% | 9.8% | |
| MACIMelar Acquisition Corp. I/Cayman | $72.6M | 44.8× | 54.4× | n/m | n/m | n/m | |
| ASRVAmeriserv Financial | $78.6M | 9.1× | 11.8× | n/m | n/m | n/m | |
| BCGBinah Capital | $18.6M | 6.8× | 20.0× | 0.1× | +8% | 2.2% | |
| VIPVulcan Infrastructure & Power | $18.4M | 16.7× | 22.5× | 0.4× | −14% | 1.0% | |
| Peer median | $46.8M | 15.5× | 22.4× | 1.0× | +11% | 13.9% |
More on Aimei Health Technology
Each number over time
Its groups
About
- Industry
- Shell Companies
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .